Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 13.30p
  • 52 Week Low: 5.13p
  • Currency: UK Pounds
  • Shares Issued: 443.23m
  • Volume: 357,003
  • Market Cap: £43.22m

Ondine reports significant financial growth

By Josh White

Date: Wednesday 24 Apr 2024

LONDON (ShareCast) - (Sharecast News) - Ondine Biomedical reported significant growth in a trading update on Wednesday, with revenues doubling to $1.2m in 2023, driven by expanded hospital deployments of 'Steriwave'.
The AIM-traded company said it now served 24 hospitals, including strategic gains in the UK and Spain, and its first deployment in Australia.

It said discussions were underway for distribution partnerships to accelerate market penetration.

Ondine was also entering the ICU market to replace mupirocin, and finalising plans for a US phase three clinical trial.

Funding support was expected from existing shareholders, while discussions with Health Insight Capital for the clinical trial were ongoing.

At 1211 BST, shares in Ondine Biomedical were down 3.7% at 6.5p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 9.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 13.30p
52 Week Low 5.13p
Volume 357,003
Shares Issued 443.23m
Market Cap £43.22m

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.27% below the market average68.27% below the market average68.27% below the market average68.27% below the market average68.27% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
39.17% above the market average39.17% above the market average39.17% above the market average39.17% above the market average39.17% above the market average
63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average
Income Not Available
Growth
33.86% above the market average33.86% above the market average33.86% above the market average33.86% above the market average33.86% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

OBI Dividends

No dividends found

Trades for 02-Apr-2025

Time Volume / Share Price
13:44 15,502 @ 9.65p
10:26 150,000 @ 9.41p
11:35 1,500 @ 9.80p
08:14 150,000 @ 9.55p
08:53 20,000 @ 9.62p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page